Novartis Shines Bright Among International Dividend Stocks
Novartis, bearing the symbol NVS, has proudly claimed its spot on the esteemed Dividend Channel “International S.A.F.E. 10” list. Honored for its exceptional dividend metrics, which notably feature a robust 3.9% yield and a steadfast record of dividend growth spanning at least five fruitful years, this pharmaceutical giant stands tall amidst its peers.
A Beacon of Stability in Stock Portfolios
A beacon of stability, Novartis emerges as an underlying asset of significant value within the Powershares International Dividend Achievers ETF (PID), constituting a solid 2.21% of the fund’s holdings, amounting to a substantial $20,259,216 worth of NVS shares as per the current data provided by the ETF Finder.
The S.A.F.E. Criteria: Why Novartis Stands Strong
Novartis secured its prestigious position on the “Dividend Channel International S.A.F.E. 10” roster by embodying the core values that the acronym S.A.F.E. represents with finesse. This accolade echoes its attributes, from Solid returns, Accelerating dividends, Flawless historical performance across five years, to the Enduring nature of its dividend payouts. Novartis epitomizes resilience and consistency in an ever-evolving market landscape.
Start slideshow:
Ten Top S.A.F.E. International Dividend Stocks »
A Foundation of Financial Resilience: Novartis’ Dividend Track Record
With an annualized dividend payout of $3.777213 per share, distributed in steady annual installments, Novartis continues to demonstrate its commitment to shareholders. The most recent dividend ex-date on 03/07/2024 further solidifies its reputation as a reliable income source. The long-term dividend history chart for NVS serves as a testament to its unwavering dividend growth over the years, a reassuring sight for investors.
A Pillar of Strength in Pharmaceutical Landscape
Operating within the Drugs & Pharmaceuticals sector, Novartis stands shoulder to shoulder with industry behemoths like Novo-Nordisk AS (NVO) and Eli Lilly (LLY). In a world where stability is a rare gem, Novartis emerges as a coveted jewel, offering investors a sanctuary of financial security amidst turbulent markets.
Further Reading:
- DNI Insider Buying
- SRRA Videos
- BRSS Shares Outstanding History
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
